Infection resulting from exposure to the fungus HISTOPLASMA.
Approved for this indication (2)
Phase 3 trials (1)
Phase 2 trials (1)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (2)